[RANKL signaling and bone diseases. Quiescent osteoclast precursors and RANKL signaling]
- PMID: 21814024
[RANKL signaling and bone diseases. Quiescent osteoclast precursors and RANKL signaling]
Abstract
It is well known that bone marrow macrophages differentiate into osteoclasts in response to M-CSF and RANKL in culture. However, the characteristics and dynamics of osteoclast precursors in vivo are not clear. Cell cycle arrest in osteoclast precursors is a prerequisite step for their differentiation into osteoclasts. We named such precursors "QOPs (cell cycle-arrested quiescent osteoclast precursors) " . Injection of 2MD [a potent analogue of 1α, 25 (OH) (2)D(3)] , RANKL, or M-CSF to mice induced osteoclast differentiation from QOPs. Moreover, osteoclasts appearing in BMP (bone morphogenetic protein) -induced ectopic bone were also differentiated from QOPs without cell proliferation. These results indicate that (1)osteoclasts are formed from QOPs in response to bone resorbing stimuli in vivo, (2) QOPs circulate in the bloodstream and settle in the right place for osteoclastogenesis. Here I review recent advances in our understanding of osteoclast precursors in vivo.
Similar articles
-
Lineage-committed osteoclast precursors circulate in blood and settle down into bone.J Bone Miner Res. 2011 Dec;26(12):2978-90. doi: 10.1002/jbmr.490. J Bone Miner Res. 2011. PMID: 21898588
-
Bone morphogenetic protein 2 enhances mouse osteoclast differentiation via increased levels of receptor activator of NF-κB ligand expression in osteoblasts.Cell Tissue Res. 2010 Nov;342(2):213-20. doi: 10.1007/s00441-010-1052-y. Epub 2010 Oct 13. Cell Tissue Res. 2010. PMID: 20941510
-
Alisol-B, a novel phyto-steroid, suppresses the RANKL-induced osteoclast formation and prevents bone loss in mice.Biochem Pharmacol. 2010 Aug 1;80(3):352-61. doi: 10.1016/j.bcp.2010.04.014. Epub 2010 Apr 20. Biochem Pharmacol. 2010. PMID: 20412788
-
Identification of cell cycle-arrested quiescent osteoclast precursors in vivo.Adv Exp Med Biol. 2010;658:21-30. doi: 10.1007/978-1-4419-1050-9_3. Adv Exp Med Biol. 2010. PMID: 19950012 Review.
-
A new member of tumor necrosis factor ligand family, ODF/OPGL/TRANCE/RANKL, regulates osteoclast differentiation and function.Biochem Biophys Res Commun. 1999 Mar 24;256(3):449-55. doi: 10.1006/bbrc.1999.0252. Biochem Biophys Res Commun. 1999. PMID: 10080918 Review.
Cited by
-
Role of inhibition of osteogenesis function by Sema4D/Plexin-B1 signaling pathway in skeletal fluorosis in vitro.J Huazhong Univ Sci Technolog Med Sci. 2015 Oct;35(5):712-715. doi: 10.1007/s11596-015-1495-1. Epub 2015 Oct 22. J Huazhong Univ Sci Technolog Med Sci. 2015. PMID: 26489627
-
Identification of key biomarkers and immune infiltration in the synovial tissue of osteoarthritis by bioinformatics analysis.PeerJ. 2020 Jan 17;8:e8390. doi: 10.7717/peerj.8390. eCollection 2020. PeerJ. 2020. PMID: 31988808 Free PMC article.
-
Ampelopsis brevipedunculata extract prevents bone loss by inhibiting osteoclastogenesis in vitro and in vivo.Molecules. 2014 Nov 12;19(11):18465-78. doi: 10.3390/molecules191118465. Molecules. 2014. PMID: 25397737 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Research Materials